Pricing Log in Create free account

Telix Pharmaceuticals Limited (TLX) vs Tango Therapeutics, Inc. (TNGX)

Telix Pharmaceuticals Limited and Tango Therapeutics, Inc. are both Biotechnology companies. Telix Pharmaceuticals Limited and Tango Therapeutics, Inc. are of similar size ($3.8B and $3.6B). Across the 8 metrics below, Telix Pharmaceuticals Limited leads on 4 and Tango Therapeutics, Inc. on 4.

Valuation

Metric TLX TNGX Biotechnology median
P/E — n/m 8.50
P/S — 52.95 9.71
P/B n/m 3.22 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 36.70 9.21
Earnings yield — (3.81%) (33.15%)
Free cash flow yield 0.00% (4.37%) (25.50%)

Profitability

Metric TLX TNGX Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin — 0.00% 0.00%
Net margin — 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (21.34%) (56.36%)
Return on assets 0.00% (18.86%) (48.04%)
Return on invested capital 0.00% (808.35%) 0.00%

Growth

Metric TLX TNGX Biotechnology median
Revenue growth (TTM) — 48.29% 6.02%
EPS growth (last fiscal year) (120.00%) 26.89% 30.26%
Revenue growth, 5-year CAGR — 52.13% 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric TLX TNGX Biotechnology median
Debt to equity 1.18 0.00 0.00
Current ratio 2.01 50.82 4.72
Net debt to EBITDA 6.25 3.08 0.96

Dividend

Metric TLX TNGX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric TLX TNGX Biotechnology median
Market cap 3.60b 3.83b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack